Contents
Academy · Research Data, Analytics & AI · Cost-utility Analysis
Cost-Utility Analysis in Health Research: Quality-Adjusted Life Years and Health Technology Assessment
Cost-utility analysis sets the cost of a treatment against a single measure intended to capture both the length and the quality of a patient’s life. This compression accounts for both the value of the method and the controversy surrounding it.
Cost-utility analysis is a form of economic evaluation that compares the costs of alternative interventions against their outcomes expressed in quality-adjusted life years (QALYs), a single measure combining length of life and health-related quality of life, so that interventions targeting entirely different conditions can be compared on a common scale.
Learning objectives
- Why cost-utility analysis uses QALYs rather than a disease-specific clinical outcome.
- How a QALY is constructed from survival time and a quality-of-life weight.
- What distinguishes cost-utility analysis from cost-effectiveness analysis more broadly.
- Where the method is used in health-system decisions.
Common misconceptions
- “Cost-utility analysis and cost-effectiveness analysis are the same thing.” Cost-effectiveness analysis is the broader category, comparing cost against any single clinical outcome measure; cost-utility analysis is specifically the form that uses QALYs, which are chosen because they permit comparison across different diseases and interventions on a single scale.
- “A QALY is just a count of years survived.” A QALY weights each year of survival by a quality-of-life index, typically ranging from 0 (a state equivalent to death) to 1 (full health); ten years at a quality weight of 0.5 therefore contribute the same number of QALYs as five years at full health.
Rationale for QALYs rather than disease-specific outcomes
Drummond and colleagues, in their standard reference text on the economic evaluation of health care programmes, explain the rationale for cost-utility analysis directly: because QALYs combine survival and quality of life into one generic unit, a health system can compare the cost per QALY gained from a cancer therapy with the cost per QALY gained from a hip replacement or a mental health intervention, a comparison that a disease-specific outcome measure (tumour response, joint mobility score) cannot support across such different conditions.
Construction of a QALY
A QALY is calculated by multiplying the time spent in a health state by a utility weight for that state, where the weight is typically anchored between 0 (equivalent to death) and 1 (full health); some scales permit states judged worse than death to score below zero. These utility weights are usually derived from standardised preference-based instruments or population valuation studies, rather than from clinicians’ judgement of severity, specifically so that the weighting reflects how patients or the general population value different health states.
Applications of cost-utility analysis in health-system decisions
Health technology assessment bodies, including the UK National Institute for Health and Care Excellence (NICE), use cost-utility analysis, expressed as an incremental cost-effectiveness ratio in cost per QALY gained, as a central input to decisions about which treatments a health system should fund. This constitutes the methodological link between cost-utility analysis and the ICER, which is examined in a separate article on the incremental cost-effectiveness ratio: the QALY is the outcome unit, and the ICER is the ratio that decision-makers compare against a threshold.
Key points
Key points
Cost-utility analysis compares interventions by their cost per QALY gained, using QALYs specifically because they combine survival and quality of life into one generic unit that allows comparison across entirely different diseases and treatments, which is why health technology assessment bodies use it as a central input to funding decisions.
Practical application
Practical application
- State the utility-weight source explicitly. The preference-based instrument or valuation study used to derive quality-of-life weights should be named, rather than a QALY estimate being presented without disclosure of how its weights were obtained.
- QALYs should be reported alongside, not instead of, clinical outcomes. The underlying clinical outcome data should be presented together with the derived QALY estimate, so that readers can evaluate the utility-weighting choices rather than seeing only the aggregated final figure.
- The analysis should be matched to the decision it will inform. If the result is intended for a health technology assessment submission, the analysis and the reported ICER should be structured according to the specific methods guide of that body (such as that of NICE) rather than a generic template.
Frequently asked questions
Some preference-based scales permit health states valued as worse than death to score below zero, though this is less common than scores bounded between 0 and 1.
The underlying definition is consistent, but the specific valuation instrument and population used to derive utility weights can differ between studies and jurisdictions, which affects comparability.
Life-years gained does not account for quality of life during those years; a treatment that extends life in a very poor state of health and one that extends life in full health would score identically on life-years alone, a difference that QALYs are specifically designed to capture.
References
- Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford University Press; 2015. read 10 October 2026. View on Oxford University Press
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). Cost-Utility Analysis in Health Research: Quality-Adjusted Life Years and Health Technology Assessment. Pubrica. https://pubrica.com/academy/concepts-definitions/cost-utility-analysis/
Pubrica Academy. “Cost-Utility Analysis in Health Research: Quality-Adjusted Life Years and Health Technology Assessment.” Pubrica, 10 Oct. 2026, pubrica.com/academy/concepts-definitions/cost-utility-analysis/.
Pubrica Academy (2026) Cost-Utility Analysis in Health Research: Quality-Adjusted Life Years and Health Technology Assessment. Pubrica. Available at: https://pubrica.com/academy/concepts-definitions/cost-utility-analysis/ (Accessed: 15 October 2026).
Pubrica Academy. “Cost-Utility Analysis in Health Research: Quality-Adjusted Life Years and Health Technology Assessment.” Pubrica. October 10, 2026. https://pubrica.com/academy/concepts-definitions/cost-utility-analysis/
Pubrica Academy, ‘Cost-Utility Analysis in Health Research: Quality-Adjusted Life Years and Health Technology Assessment’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/concepts-definitions/cost-utility-analysis/> accessed 15 October 2026.
Pubrica Academy. Cost-Utility Analysis in Health Research: Quality-Adjusted Life Years and Health Technology Assessment. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/concepts-definitions/cost-utility-analysis/
Pubrica Academy, “Cost-Utility Analysis in Health Research: Quality-Adjusted Life Years and Health Technology Assessment,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/concepts-definitions/cost-utility-analysis/
@misc{cost_utility_analysis_2026,
author = {{Pubrica Academy}},
title = {Cost-Utility Analysis in Health Research: Quality-Adjusted Life Years and Health Technology Assessment},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/concepts-definitions/cost-utility-analysis/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Cost-utility analysis reporting stub
For use when reporting a cost-utility analysis in a manuscript or submission.
Comparator(s): ____ Utility-weight source/instrument: ____ Time horizon: ____ Discount rate applied (costs and outcomes): ____ Total QALYs per arm: ____ Total cost per arm: ____ Incremental cost per QALY gained: ____
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
The Pubrica health-economics team develops and reports cost-utility analyses to the standards expected by health technology assessment bodies, with utility-weight sources and discounting assumptions disclosed explicitly.